Antimicrobial Resistance Threatens Global Health

Passage

Antimicrobial resistance, the process by which bacteria, viruses, fungi, and parasites evolve mechanisms to withstand the drugs designed to eliminate them, has emerged as one of the most serious threats to global public health in the contemporary era, with the World Health Organization identifying it as a priority concern that could claim ten million lives annually by 2050 if current trajectories continue unchecked. The primary driver of resistance development is the inappropriate and excessive use of antibiotics, both in human clinical settings, where they are frequently prescribed for viral infections against which they have no efficacy, and in industrial agriculture, where they are administered prophylactically to livestock in conditions that promote the emergence and horizontal transfer of resistance genes among bacterial populations. Once resistant strains establish themselves, they can spread rapidly across national borders through international travel and global food supply chains, rendering previously straightforward infections such as urinary tract infections, pneumonia, and surgical site infections increasingly difficult or impossible to treat with existing pharmacological agents. Compounding this crisis is the dramatic slowdown in antibiotic discovery and development since the mid-twentieth century, as pharmaceutical companies have largely withdrawn from this therapeutic area due to limited financial returns relative to development costs. Addressing antimicrobial resistance therefore demands coordinated international governance, reformed agricultural practices, enhanced diagnostic stewardship, and renewed public and private investment in novel antimicrobial therapies.